Synthesis, biologicalevaluation, and molecular modeling of (E)-2-aryl-5-styryl-1,3,4-oxadiazolederivatives as acetylcholine esterase inhibitors

Medicinal Chemistry Research

Volumn 23, Issue 4, 2014, Pages 2080-2092

  Kamal, Ahmed ^a   Shaik, Anver Basha ^a   Reddy, G Narender ^a   Kumar, C Ganesh ^a   Joseph, Joveeta ^a   Kumar, G Bharath ^a   Purushotham, Uppula ^a   Sastry, G Narahari ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

2 Aryl 5 styryl 1,3,4 oxadiazoles; Acetylcholine esterase inhibitors; Derivatives; Molecular modeling

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; ACETYLCHOLINESTERASE; OXADIAZOLE DERIVATIVE;

ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; ENZYME CONFORMATION; IN VITRO STUDY; MOLECULAR DOCKING; MOLECULAR MODEL;

EID: 84899023491     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-013-0786-y     Document Type: Article

References (28)

1. Alam MM, Shaharyar M, Hamid H, Nazreen S, Haider S, Alam MS (2011) Synthesis of novel 8-hydroxy quinolin based 1,3,4-oxadiazoles and S-substituted 1,2,4-triazole derivatives and evaluation of their anti-inflammatory, analgesic, ulcerogenic and anti-microbial activities. Med Chem 7(6):663-673
2. Al-Kazzaz FF, Al-Hasani RAM, Zyzaffon N (2011) Sensitivity of serum acetylcholine esterase toward derivatives of oxadiazole. Eng Tech J 29(4):651-664
3. Alvarez A, Opazo C, Alarcon R, Garrido J, Inestrossa NC (1997) Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. J Mol Biol 272(3):348-361 (Pubitemid 27410049)
4. Alvarez A, Alarcon R, Opazo C, Campos EO, Munoz FJ, Calderon FH, Dajas F, Gentry MK, Doctor PB, De Mello FG, Inestrosa NC (1998) Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J Neurosci 18(9):3213-3223 (Pubitemid 28186014)
5. Andreani A, Cavalli A, Granaiola M, Guardigli M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Recanatini M, Roda AJ (2001) Synthesis and screening for antiacetylcholinesterase activity of (1-benzyl-4-oxopiperidin-3-ylidene) methylindoles and -pyrroles related to donepezil. J Med Chem 44(23):4011-4014 (Pubitemid 33051491)
6. Badrinarayan P, Sastry GN (2011) Sequence, structure, and active site analyses of p38 MAP kinase: exploiting DFG-out conformation as a strategy to design new type II leads. J Chem Inf Model 51(1):115-129
7. Badrinarayan P, Srivani P, Sastry GN (2011) Design of 1-arylsulfamido-2-alkylpiperazine derivatives as secreted PLA2 inhibitors. J Mol Model 17(4):817-831
8. Bartus RT, Dean RLR, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558):408-414
9. Bhattacharya J, Patel K, Tailor P, Karthikeyan C, Moorthy NSH, Trivedi P (2010) Design, synthesis and characterization of novel 1,3,4-oxadiazole dimmers from benzoic acids. Int J Chem Technol Res 2:2055-2062
10. Davis KL, Powchik P (1995) Tacrine. Lancet 45(8950):625-630
11. De Ferrari GV, CanalesMA, Shin I, Weiner LM, Silman I, Inestrosa NC (2001) A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. Biochemistry 40(35):10447-10457 (Pubitemid 32816655)
12. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95
13. Gaonkar SL, Rai KM, Prabhuswamy B (2006) Synthesis and antimicrobial studies of a new series of 2-[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]-5- substituted-1,3,4-oxadiazoles. Eur J Med Chem 41(7):841-846 (Pubitemid 44015976)
14. Jha KK, Samad A, Kumar Y, ShaharyarM,Khosla RL, Jain J, Kumar V, Singh P (2010) Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives. Eur J Med Chem 45(11):4963-4967
15. Johansson M, Hellström-Lindahl E, Nordberg A (1996) Steady-state pharmacokinetics of tacrine in long-term treatment of Alzheimer patients. Dementia 7(2):111-117 (Pubitemid 26048425)
16. Kawakami Y, Inoue A, Kawai T, Wakita M, Sugimoto H, Hopfinger AJ (1996) The rationale for E2020 as a potent acetylcholinesterase inhibitor. Bioorg Med Chem 4(9):1429-1446 (Pubitemid 26319994)
17. Kryger G, Silman I, Sussman JL (1999) Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure 7(3):297-307 (Pubitemid 29159689)
18. Lee L, Robb LM, Lee M, Davis R, Mackay H, Chavda S, Babu B, O'Brien EL (2010) Design, synthesis, and biological evaluations of 2,5-diaryl-2,3-dihydro- 1,3,4-oxadiazoline analogs of combretastatin-A4. J Med Chem 53(1):325-334
19. Narayana B, Vijayaraj KK, Ashalata BV, Kumari NS (2005) Synthesis of some new 2-(6-methoxy-2-naphthyl)-5-aryl-1,3,4-oxadiazoles as possible non-steroidal anti-inflammatory and analgesic agents. Arch Pharm (Weinheim) 338(8):373-377 (Pubitemid 41169997)
20. Prous J, Rabasseda X, Castaner J (1996) Cognition enhancer acetylcholinesterase inhibitor. Drugs Future 19(7):656-658
21. Rainer M (1997) Galanthamine in Alzheimer's disease: a new alternative to tacrine? CNS Drugs 7(2):89-97
22. Ravindra GK, Achaiah G, Sastry GN (2008) Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking. Eur J Med Chem 43(4):830-838 (Pubitemid 351446153)
23. Shi W, Qian X, Zhang R, Song G (2001) Synthesis and quantitative structure-activity relationships of new 2,5-disubstituted-1,3,4-oxadiazoles. J Agric Food Chem 49(1):124-130 (Pubitemid 32104499)
24. Singh P, Sharma PK, Sharma JK, Upadhyay A, Kumar N (2012) Synthesis and evaluation of substituted diphenyl-1,3,4-oxadiazole derivatives for central nervous system depressant activity. Org Med Chem Lett 2:8. doi:10.1186/2191- 2858-2-8
25. Srivastava HK, Chourasia M, Kumar D, Sastry GN (2011) Comparison of computational methods to model DNA minor groove binders. J Chem Inf Model 51(3):558-571
26. Tan TM, Chen Y, Kong KH, Bai J, Li Y, Lim SG, Ang TH, Lam Y (2006) Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted- sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents. Antiviral Res 71(1):7-14
27. Wagstaff AJ, McTavish D (1994) Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drugs Aging 4(6):510-540 (Pubitemid 2093496)
28. Zarghi A, Tabatabai SA, Faizi M, Ahadian A, Navabi P, Zanganeh V, Shafiee A (2005) Synthesis and anticonvulsant activity of new 2-substituted-5-(2- benzyloxyphenyl)-1,3,4-oxadiazoles. Bioorg Med Chem Lett 15(7):1863-1865 (Pubitemid 40380748)